Novartis to acquire radiopharma treatment developer

22-10-2018

Novartis to acquire radiopharma treatment developer

NicoElnino / iStockphoto.com

Novartis is planning to acquire Endocyte, an Indiana-based biotech, to accelerate its development of radiopharmaceuticals.


Novartis, Endocyte, acquisition, merger, prostate cancer, radiopharmaceuticals, diagnostics, treatment, medical need, cancer treatment, oncology, research

LSIPR